TY - JOUR
T1 - Tuning pH sensitive chitosan and cisplatin over spinel ferrite/silica nanocomposite for anticancer activity in MCF-7 cell line
AU - Jermy, Rabindran
AU - Ravinayagam, Vijaya
AU - Alamoudi, Widyan
AU - Almohazey, Dana
AU - Elanthikkal, Silviya
AU - Dafalla, Hatim
AU - Rehman, Suriya
AU - Chandrasekar, Govindasamy
AU - Baykal, Abdulhadi
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/6
Y1 - 2020/6
N2 - 30%MFe2O4/Silica/Chitosan (M = Ni, Cu, Co and Mn) was prepared by pre-wrapping chitosan (CS) over hydrophilic silica (HYPS) for cisplatin (cis-Pt) release. CS coating was optimized with 0.06 wt% and 0.6 wt % at different pH (5, 6 and 6.5). CS (0.6 wt%) coated over CuFe2O4/HYPS/cis-Pt by optimizing two ways of pH adjustments. In method I, cis-Pt (0.15 mmolg−1 of nanocarrier) was preloaded with CuFe2O4/HYPS, then immersed in CS of pH 6.0 (cis-Pt/CuFe2O4/HYPS/CS). In method II, CS was pre-wrapped over CuFe2O4/HYPS and then loaded with cis-Pt (CS/CuFe2O4/HYPS/cis-Pt). CoFe2O4/HYPS showed ferromagnetic behavior with high magnetization (14.15 emu/g), while MnFe2O4/HYPS showed a super paramagnetic behavior (1.49 emu/g). CuFe2O4/HYPS showed preferable paramagnetic effect (7.65 emu/g) with cis-Pt release of about 64% for 72 h cis-Pt/CuFe2O4/HYPS and cis-Pt/CuFe2O4/HYPS/CS (0.025–0.5 mg/ml) were studied in MCF-7 and HEK293. CuFe2O4/HYPS was not cytotoxic, while cis-Pt/CuFe2O4/HYPS/CS, prepared by method I showed a non-significant anti-cancer effect due to premediated cis-Pt release. Conversely, cis-Pt/CuFe2O4/HYPS and CS/CuFe2O4/HYPS/cis-Pt prepared by method II significantly reduced cell viability in dose dependent manner. MCF7 cells treated with CS/CuFe2O4/HYPS/cis-Pt (method II) at lowest concentration (0.025 mg/ml) resulted in 70.7% cell viability, whereas HEK293 cells had a 95% viability, thus making the nanocomposite an effective drug delivery system.
AB - 30%MFe2O4/Silica/Chitosan (M = Ni, Cu, Co and Mn) was prepared by pre-wrapping chitosan (CS) over hydrophilic silica (HYPS) for cisplatin (cis-Pt) release. CS coating was optimized with 0.06 wt% and 0.6 wt % at different pH (5, 6 and 6.5). CS (0.6 wt%) coated over CuFe2O4/HYPS/cis-Pt by optimizing two ways of pH adjustments. In method I, cis-Pt (0.15 mmolg−1 of nanocarrier) was preloaded with CuFe2O4/HYPS, then immersed in CS of pH 6.0 (cis-Pt/CuFe2O4/HYPS/CS). In method II, CS was pre-wrapped over CuFe2O4/HYPS and then loaded with cis-Pt (CS/CuFe2O4/HYPS/cis-Pt). CoFe2O4/HYPS showed ferromagnetic behavior with high magnetization (14.15 emu/g), while MnFe2O4/HYPS showed a super paramagnetic behavior (1.49 emu/g). CuFe2O4/HYPS showed preferable paramagnetic effect (7.65 emu/g) with cis-Pt release of about 64% for 72 h cis-Pt/CuFe2O4/HYPS and cis-Pt/CuFe2O4/HYPS/CS (0.025–0.5 mg/ml) were studied in MCF-7 and HEK293. CuFe2O4/HYPS was not cytotoxic, while cis-Pt/CuFe2O4/HYPS/CS, prepared by method I showed a non-significant anti-cancer effect due to premediated cis-Pt release. Conversely, cis-Pt/CuFe2O4/HYPS and CS/CuFe2O4/HYPS/cis-Pt prepared by method II significantly reduced cell viability in dose dependent manner. MCF7 cells treated with CS/CuFe2O4/HYPS/cis-Pt (method II) at lowest concentration (0.025 mg/ml) resulted in 70.7% cell viability, whereas HEK293 cells had a 95% viability, thus making the nanocomposite an effective drug delivery system.
KW - Cancer therapy
KW - Chitosan
KW - Cisplatin
KW - Multifunctional
KW - Spinel ferrite
UR - https://www.scopus.com/pages/publications/85083004182
U2 - 10.1016/j.jddst.2020.101711
DO - 10.1016/j.jddst.2020.101711
M3 - Article
AN - SCOPUS:85083004182
SN - 1773-2247
VL - 57
JO - Journal of Drug Delivery Science and Technology
JF - Journal of Drug Delivery Science and Technology
M1 - 101711
ER -
